Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Urological Cancers
  •  Immunotherapy
  •  Neoadjuvant Therapy
  •  Palliative Care
  •  Lymphoma
  •  Chemotherapy and Radiotherapy
  •  Endometrial Cancer
  •  Cervical Cancer

Abstract

Citation: Clin Oncol. 2020;5(1):1691.DOI: 10.25107/2474-1663.1691

Sarcoid-like Reaction Detected by 18F-FDG PET/CT in a Patient with Gastrointestinal Stromal Tumor (GIST) PostTherapy with Multi-Targeted Receptor Tyrosine Kinase (RTK) Inhibitor Sunitinib

Mahmoud Aly, Chaitanya Rojulpote, Esha Kothekar1, Therese Seierstad and Mona-Elisabeth Revheim

Department of Radiology, Hospital of the University of Pennsylvania, USA Division of Radiology and Nuclear Medicine, Oslo University Hospital, Norway Institute of Clinical Medicine, University of Oslo, Norway

*Correspondance to: Mona-Elisabeth Revheim 

 PDF  Full Text Case Report | Open Access

Abstract:

A 52 years old male patient, with a history of Gastrointestinal Stromal Tumor (GIST) in the small intestines with metastasis to the liver and peritoneum, with pathology showing mutation type Exon11. The patient underwent 18F-FDG PET/CT scan that showed lesions with moderate FDG uptake. The patient was given Sunitinib 50 mg p.os and a 18F-FDG PET/CT scan performed two weeks later showed marked reduced FDG uptake in all lesions. However, due to side effects, Sunitinib was first discontinued and then restarted after three weeks with 25 mg (half dose). A follow-up 18F-FDG PET/ CT scan three months later showed stable disease but high FDG uptake in multiple cervical, axillary and mediastinal lymph nodes.

Keywords:

Sarcoid; FDG PET/CT; GIST; RTK; Sunitinib

Cite the Article:

Aly M, Rojulpote C, Kothekar E, Seierstad T, Revheim M-E. Sarcoid-like Reaction Detected by 18F-FDG PET/ CT in a Patient with Gastrointestinal Stromal Tumor (GIST) Post-Therapy with Multi-Targeted Receptor Tyrosine Kinase (RTK) Inhibitor Sunitinib. Clin Oncol. 2020; 5: 1691.

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Identification of Ethylenediurea and Benzyl (Phenoxy) Acetic Acid Derivatives, a Potential Cocktail Therapy for Ischemia
 Abstract  PDF  Full Text
Enhanced Recovery after Surgery Protocol for Patients Undergoing Radical Cystectomy
 Abstract  PDF  Full Text
View More...